REFERENCES
1. Durmaz AA, Karaca E, Demkow U, Toruner G, Schoumans J, Cogulu O. Evolution of genetic techniques: past, present, and beyond. Biomed Res Int. 2015;2015:461524.
2. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33:D514-7.
4. Tan C. The nature of the race-differential chromosomes in Drosophila montium De Meijere. Sci Rec 1942:178-87.
5. Tan CC. Mosaic dominance in the inheritance of color patterns in the lady-bird beetle, harmonia axyridis. Genetics. 1946;31:195-210.
10. Hsu TC, Pomerat CM. Mammalian chromosomes in vitro: II. A method for spreading the chromosomes of cells in tissue culture. J Hered. 1953;44:23-30.
13. Hsu TC. Human and mammalian cytogenetics: an historical perspective. New York: Spring-Verlag; 1979.
15. Huang RC, Bonner J. Histone, a suppressor of chromosomal RNA synthesis. Proc Natl Acad Sci U S A. 1962;48:1216-22.
16. Wu R. Nucleotide sequence analysis of DNA. I. Partial sequence of the cohesive ends of bacteriophage lambda and 186 DNA. J Mol Biol. 1970;51:501-21.
19. Cheung MC, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet. 1996;14:264-8.
20. Kan YW, Dozy AM. Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci U S A. 1978;75:5631-5.
21. Taylor JM, Dozy A, Kan YW, et al. Genetic lesion in homozygous alpha thalassaemia (hydrops fetalis). Nature. 1974;251:392-3.
22. Kan YW, Dozy AM, Varmus HE, et al. Deletion of alpha-globin genes in haemoglobin-H disease demonstrates multiple alpha-globin structural loci. Nature. 1975;255:255-6.
23. Wong V, Ma HK, Todd D, Golbus MS, Dozy AM, Kan YW. Diagnosis of homozygous alpha-thalassemia in cultured amniotic-fluid fibroblasts. N Engl J Med. 1978;298:669-70.
24. Ye L, Wang J, Tan Y, et al. Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: an approach for treating sickle cell disease and β-thalassemia. Proc Natl Acad Sci U S A. 2016;113:10661-5.
25. Tan YT, Ye L, Xie F, et al. CRISPR/Cas9-mediated gene deletion efficiently retards the progression of Philadelphia-positive acute lymphoblastic leukemia in a p210 BCR-ABL1T315I mutation mouse model. Haematologica. 2020;105:e232-6.
26. Chen TL, Yang H. History of the Association of Chinese Geneticists in America (ACGA). N Am J Med Sci 2013;6:171-2. Available from: https://najms.com/index.php/najms/article/view/197. [Last accessed on 14 Aug 2026].
27. Chow LT, Gelinas RE, Broker TR, Roberts RJ. An amazing sequence arrangement at the 5’ ends of adenovirus 2 messenger RNA. Cell. 1977;12:1-8.
28. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science. 1987;235:1394-9.
29. Tsui LC, Buchwald M, Barker D, et al. Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science. 1985;230:1054-7.
30. Rommens JM, Iannuzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989;245:1059-65.
31. Scherer SW, Cheung J, MacDonald JR, et al. Human chromosome 7: DNA sequence and biology. Science. 2003;300:767-72.
32. Ledley FD, Grenett HE, McGinnis-Shelnutt M, Woo SL. Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells. Proc Natl Acad Sci U S A. 1986;83:409-13.
33. Ledley FD, Grenett HE, DiLella AG, Kwok SC, Woo SL. Gene transfer and expression of human phenylalanine hydroxylase. Science. 1985;228:77-9.
34. Peng H, Armentano D, MacKenzie-Graham L, et al. Retroviral-mediated gene transfer and expression of human phenylalanine hydroxylase in primary mouse hepatocytes. Proc Natl Acad Sci U S A. 1988;85:8146-50.
35. Cristiano RJ, Smith LC, Kay MA, Brinkley BR, Woo SL. Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc Natl Acad Sci U S A. 1993;90:11548-52.
36. Lu D, Gong X, Fang Y, et al. Correction of RNA splicing defect in β654-thalassemia mice using CRISPR/Cas9 gene-editing technology. Haematologica. 2022;107:1427-37.
37. Huang SZ, Huang Y, Chen MJ, Zeng FY, Ren ZR, Zeng YT. Selection of in vitro produced, transgenic embryos by nested PCR for efficient production of transgenic goats. Theriogenology. 2001;56:545-56.
38. Yang XY, Li H, Ma QW, et al. Improved efficiency of bovine cloning by autologous somatic cell nuclear transfer. Reproduction. 2006;132:733-9.
39. Huang SZ, Huang YA, Chen MJ, et al. A study of transgenic IVF cattle integrated with the human serum albumin gene. Acta Genetica Sinica. 2000;27:573-9.
40. Xu T, Rubin GM. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development. 1993;117:1223-37.
41. Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 1995;121:1053-63.
42. Huang H, Potter CJ, Tao W, et al. PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development. 1999;126:5365-72.
43. Tao W, Zhang S, Turenchalk GS, et al. Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet. 1999;21:177-81.
44. Potter CJ, Huang H, Xu T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell. 2001;105:357-68.
45. Potter CJ, Pedraza LG, Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol. 2002;4:658-65.
46. Kikuchi T, Yang HW, Pennybacker M, et al. Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail. J Clin Invest. 1998;101:827-33.
47. Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004;428:486.
48. Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A. 2005;102:4134-9.
49. Cox DN, Chao A, Baker J, Chang L, Qiao D, Lin H. A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell self-renewal. Genes Dev. 1998;12:3715-27.
50. Grivna ST, Beyret E, Wang Z, Lin H. A novel class of small RNAs in mouse spermatogenic cells. Genes Dev. 2006;20:1709-14.
51. Huang XA, Yin H, Sweeney S, Raha D, Snyder M, Lin H. A major epigenetic programming mechanism guided by piRNAs. Dev Cell. 2013;24:502-16.
52. Juliano CE, Reich A, Liu N, et al. PIWI proteins and PIWI-interacting RNAs function in Hydra somatic stem cells. Proc Natl Acad Sci U S A. 2014;111:337-42.
54. Zhao H, Zhang S, Merikangas KR, et al. Transmission/disequilibrium tests using multiple tightly linked markers. Am J Hum Genet. 2000;67:936-46.
55. Lu Q, Li B, Ou D, et al. A powerful approach to estimating annotation-stratified genetic covariance via GWAS summary statistics. Am J Hum Genet. 2017;101:939-64.
56. Hu Y, Li M, Lu Q, et al. ; Alzheimer’s Disease Genetics Consortium. A statistical framework for cross-tissue transcriptome-wide association analysis. Nat Genet. 2019;51:568-76.
57. Zhou G, Chen T, Zhao H. SDPRX: a statistical method for cross-population prediction of complex traits. Am J Hum Genet. 2023;110:13-22.
58. Liu XZ, Walsh J, Mburu P, et al. Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nat Genet. 1997;16:188-90.
59. Liu X, Han D, Li J, et al. Loss-of-function mutations in the PRPS1 gene cause a type of nonsyndromic X-linked sensorineural deafness, DFN2. Am J Hum Genet. 2010;86:65-71.
60. Yan D, Zhu Y, Walsh T, et al. Mutation of the ATP-gated P2X2 receptor leads to progressive hearing loss and increased susceptibility to noise. Proc Natl Acad Sci U S A. 2013;110:2228-33.
61. Du W, Ergin V, Loeb C, et al. Rescue of auditory function by a single administration of AAV-TMPRSS3 gene therapy in aged mice of human recessive deafness DFNB8. Mol Ther. 2023;31:2796-810.
62. Wei W, Zhu W, Silver S, et al. Single-dose genome editing therapy rescues auditory and vestibular functions in adult mice with DFNA41 deafness. J Clin Invest. 2025;135:e187872.
63. Marom R, Song IW, Busse EC, et al. The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect. J Clin Invest. 2024;134:e170369.
64. Chen YT, Jiang MM, Leynes C, et al. ATRX silences Cartpt expression in osteoblastic cells during skeletal development. J Clin Invest. 2025;135:e163587.
65. Lee B, Godfrey M, Vitale E, et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature. 1991;352:330-4.
66. Lee B, Diaz GA, Rhead W, et al. ; UCD Consortium. Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder. Genet Med. 2015;17:561-8.
67. Jin P, Zarnescu DC, Zhang F, et al. RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron. 2003;39:739-47.
68. Jin P, Zarnescu DC, Ceman S, et al. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci. 2004;7:113-7.
69. Kang Y, Zhou Y, Li Y, et al. A human forebrain organoid model of fragile X syndrome exhibits altered neurogenesis and highlights new treatment strategies. Nat Neurosci. 2021;24:1377-91.
70. Kong HE, Lim J, Linsalata A, et al. Identification of PSMB5 as a genetic modifier of fragile X-associated tremor/ataxia syndrome. Proc Natl Acad Sci U S A. 2022;119:e2118124119.
71. Jin Y, Cao Y, Ma W, et al. Integrative transcriptome-wide association analyses reveal PRKCG-linked GABAergic dysfunction in Fragile X-associated tremor/ataxia syndrome. Nat Commun. 2026;17:1418.
72. Szulwach KE, Li X, Li Y, et al. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci. 2011;14:1607-16.
73. Yu M, Hon GC, Szulwach KE, et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell. 2012;149:1368-80.
74. Song CX, Szulwach KE, Dai Q, et al. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell. 2013;153:678-91.
75. Shafik AM, Peng Y, Zhang Z, et al. Multi-region m6A epitranscriptome profiling of the human brain reveals spatial and temporal variation and enrichment of disease-associated loci. Nat Neurosci. 2026;29:195-205.
76. Shan G, Li Y, Zhang J, et al. A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol. 2008;26:933-40.
77. Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157:1262-78.
78. Shalem O, Sanjana NE, Hartenian E, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343:84-7.
79. Weinstein JA, Regev A, Zhang F. DNA microscopy: optics-free spatio-genetic imaging by a stand-alone chemical reaction. Cell. 2019;178:229-41.e16.
80. Vedula RS, Karp HQ, Koob J, et al. CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias. Blood. 2024;144:1290-9.
81. Chu JY, Huang W, Kuang SQ, et al. Genetic relationship of populations in China. Proc Natl Acad Sci U S A. 1998;95:11763-8.
82. Tian Y, Wang W, Lautrup S, et al. WRN promotes bone development and growth by unwinding SHOX-G-quadruplexes via its helicase activity in Werner Syndrome. Nat Commun. 2022;13:5456.
83. Li Q, Gao Z, Chen Y, Guan MX. The role of mitochondria in osteogenic, adipogenic and chondrogenic differentiation of mesenchymal stem cells. Protein Cell. 2017;8:439-45.
84. Wang J, Ye F, Chai H, et al. Advances and applications in single-cell and spatial genomics. Sci China Life Sci. 2025;68:1226-82.
85. Shu W, Zhou Q, Zhang H, et al. Medical genetics specialty and allied professional systems in North America and Europe and its impacts on healthcare - a report of the Association of Chinese Geneticists in America. Chin J Med Genet. 2016;33:396-401.
86. Li P, Zhang HZ, Li M, et al. Progress and perspective for professional training in medical genetics and genomics: a report of the Association of Chinese Geneticists in America. N Am J Med Sci 2013;6:173-80. Available from: https://distantreader.org/stacks/journals-ojs/najms/najms-198.pdf. [Last accessed on 14 Aug 2026].
87. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485-7.
88. Wong LC, Chen T, Wang J, et al. Interpretation of mitochondrial tRNA variants. Genet Med. 2020;22:917-26.
89. Sun L, Liang B, Zhu L, Shen Y, He L. The rise of the genetic counseling profession in China. Am J Med Genet C Semin Med Genet. 2019;181:170-6.
90. Gorkin DU, Barozzi I, Zhao Y, et al. An atlas of dynamic chromatin landscapes in mouse fetal development. Nature. 2020;583:744-51.
91. Zhu C, Preissl S, Ren B. Single-cell multimodal omics: the power of many. Nat Methods. 2020;17:11-4.
92. Li MM, Datto M, Duncavage EJ, et al. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017;19:4-23.
93. Cen X, Zou J, Tong Y, Zhao Y, Li Y, Yang H. Redefining imaging genomics for the next decade. Sci Bull. 2025;70:3720-3.
94. Ying D, Cheung CL, O CK, et al. ; Hong Kong Genome Project. Population-scale genomic medicine with the Hong Kong Genome Project. Nat Med. 2026;32:2277-87.
95. Zhang J, Liu H, Luo S, et al. Live birth derived from oocyte spindle transfer to prevent mitochondrial disease. Reprod Biomed Online. 2017;34:361-8.
96. Lau YF, Kan YW. Versatile cosmid vectors for the isolation, expression, and rescue of gene sequences: studies with the human alpha-globin gene cluster. Proc Natl Acad Sci U S A. 1983;80:5225-9.
97. Lau YF, Kan YW. Direct isolation of the functional human thymidine kinase gene with a cosmid shuttle vector. Proc Natl Acad Sci U S A. 1984;81:414-8.
98. Roa BB, Pulliam J, Eng CM, Cheung SW. Evolution of prenatal genetics: from point mutation testing to chromosomal microarray analysis. Expert Rev Mol Diagn. 2005;5:883-92.
99. Bi W, Borgan C, Pursley AN, et al. Comparison of chromosome analysis and chromosomal microarray analysis: what is the value of chromosome analysis in today’s genomic array era? Genet Med. 2013;15:450-7.
100. Yang L, Renauer PA, Tang K, et al. OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours. Nature. 2026;652:740-51.
